Business Description
BerGenBio ASA
ISIN : NO0010650013
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1676.38 | |||||
Equity-to-Asset | 0.86 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 6.92 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -68.8 | |||||
3-Year EBITDA Growth Rate | 0.2 | |||||
3-Year EPS without NRI Growth Rate | 0.2 | |||||
3-Year FCF Growth Rate | -0.4 | |||||
3-Year Book Growth Rate | -34.4 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.01 | |||||
Quick Ratio | 7.01 | |||||
Cash Ratio | 6.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.6 | |||||
Shareholder Yield % | -51.66 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -57758.1 | |||||
Net Margin % | -58086.12 | |||||
FCF Margin % | -69814.91 | |||||
ROE % | -181.95 | |||||
ROA % | -123.3 | |||||
ROIC % | -815.25 | |||||
ROC (Joel Greenblatt) % | -140981.16 | |||||
ROCE % | -180.43 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 60.6 | |||||
PB Ratio | 2.98 | |||||
Price-to-Tangible-Book | 3.02 | |||||
EV-to-EBIT | -1.56 | |||||
EV-to-Forward-EBIT | -0.6 | |||||
EV-to-EBITDA | -1.58 | |||||
EV-to-Forward-EBITDA | -0.6 | |||||
EV-to-Revenue | 905.89 | |||||
EV-to-FCF | -1.18 | |||||
Price-to-Net-Current-Asset-Value | 3.02 | |||||
Price-to-Net-Cash | 3.63 | |||||
Earnings Yield (Greenblatt) % | -63.87 | |||||
FCF Yield % | -52.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BerGenBio ASA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil kr) | 0.389 | ||
EPS (TTM) (kr) | -1.263 | ||
Beta | 0.67 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (kr) | 0 | ||
20-Day SMA (kr) | 3.445 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (kr) | 3.445 - 3.445 | ||
Shares Outstanding (Mil) | 2,688.69 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BerGenBio ASA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BerGenBio ASA Stock Events
Event | Date | Price(kr) | ||
---|---|---|---|---|
No Event Data |
BerGenBio ASA Frequently Asked Questions
What is BerGenBio ASA(OSTO:BGBIOO)'s stock price today?
When is next earnings date of BerGenBio ASA(OSTO:BGBIOO)?
Does BerGenBio ASA(OSTO:BGBIOO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |